Investigating the effect of exercise during dialysis on blood phosphorus and urea clearance

Not Applicable

Not yet recruiting

• Conditions: Condition 1: Hyperphosphatemia. Condition 2: Uremia.; Chronic kidney disease, stage 5; N18.5

• Registration Number: IRCT20230704058663N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

All dialysis patients who are over 18 years old.
All dialysis patients who have a fixed number of sessions per week and undergo hemodialysis 3 times a week and each session lasts for 4 hours.
All dialysis patients who have undergone hemodialysis for more than 3 months.
All dialysis patients who use a permanent vascular access.
All dialysis patients who are able to perform active range of motion exercises and pedal independently.
All dialysis patients who have the ability to learn exercises and do not have mental disabilities.
All dialysis patients who had stable hemodynamics during hemodialysis sessions in the last 1 month.

Exclusion Criteria

pregnancy.
Patients with symptomatic and severe aortic stenosis
Patients who have a history of lung disease that requires oxygen therapy
Patients who do not have a history of stroke or transient ischemic attacks in the last 3-6 months
Patients who have a history of heart attack and unstable angina in the past 3-6 months.
Patients with a history of ischemic heart disease
Patients who have any disorders in the musculoskeletal system (orthopedic problems, lower limb amputations, etc.) that prevent them from performing the desired sports activities
Patients with uncontrolled blood pressure.
Patients with uncontrolled diabetes.
Patients who have a history of moderate to severe heart failure (class =II according to New York Heart Association criteria).
Patients with a history of angina pectoris grade 2-4 according to the criteria of the Canadian Heart and Vascular Association

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood phosphorus level. Timepoint: At the beginning of the study (before the start of the intervention) and 1 and 2 months after the start of the intervention. Method of measurement: Sending the blood sample to the laboratory.;Blood urea level. Timepoint: At the beginning of the study (before the start of the intervention) and 1 and 2 months after the start of the intervention. Method of measurement: Sending the blood sample to the laboratory.

Secondary Outcome Measures

Name	Time	Method
Quality of life. Timepoint: mortality. Method of measurement: hospitalization.